Collaborations, Competitor News, Data Partnership

CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer

March 17, 2022 06:30 ET | Source: Centogene NV In November 2019, CENTOGENE first announced the signing of a data access and collaboration agreement to discover and validate novel genetic and biochemical targets for the potential development of new therapies for rare diseases New research phase aims to substantiate earlier results and…

Competitor News, Product Updates

Ciox Health Introduces Social Determinant Insights to Expand Data Utilities Suite

The Social Determinants Insights data set consists of over 400 raw attributes, three Risk Scores and up to date demographic data such as phone, address, and email contact information. ALPHARETTA, Ga., March 17, 2022 /PRNewswire/ — Ciox Health®, a Datavant company, today announced the addition of Social Determinant Insights™ to the recently announced Ciox…

Competitor News, Product Updates

EVERSANA unveils global price and market access solution NAVLIN by EVERSANA

Next generation price and market access platform combining data, software and insights into single ecosystem CHICAGO, March 17, 2022 /PRNewswire/ — EVERSANA™, the pioneer of next generation commercial services to the global life sciences industry, today unveiled NAVLIN by EVERSANA™, a new, comprehensive ecosystem of price and access solutions to help established and emerging pharmaceutical…

Competitor News, Oncology, Product Updates

U.S. FDA Approves FoundationOne®CDx as a Companion Diagnostic for EGFR Therapeutics Targeting Exon 19 Deletions or Exon 21 Substitutions in Non-Small Cell Lung Cancer

Foundation Medicine’s tissue-based test is the first and only comprehensive genomic profiling test to be approved as a companion diagnostic for a third group of targeted therapies March 17, 2022 06:57 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. a pioneer in molecular profiling for cancer, today announced it has…

Collaborations, Competitor News

PathAI Partners with Datavant to enable Biopharma Companies to Connect Digital Pathology Data for Research

BOSTON and SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) — PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology, and Datavant, the leader in helping organizations securely connect health data, announced a collaboration to enable compliant connectivity of PathAI’s pathology platform to life sciences trial data and other real-world data. PathAI’s…

Collaborations, Competitor News, Oncology

Fight CRC and Komodo Health Launch New Interactive Map to Connect Colorectal Cancer Patients with Specialists Nationwide

Powered by Komodo’sHealthcare Map™, Provider Finder connects patients with top specialists by geography and expertise March 16, 2022 08:00 AM Eastern Daylight Time WASHINGTON–(BUSINESS WIRE)–Today, Komodo Health and Fight Colorectal Cancer (Fight CRC) expand their partnership with the introduction of the Fight CRC Provider Finder, a digital tool to help…

Collaborations, Competitor News

Datavant Expands Partnership with ZS to Connect Real World Data for Biopharmaceutical Companies

The partnership will unlock new use cases across clinical development, medical affairs, HEOR, and commercial functions March 16, 2022 08:45 ET | Source: Datavant SAN FRANCISCO, March 16, 2022 (GLOBE NEWSWIRE) — Datavant, the leader in securely connecting health data, and ZS, a global professional services firm, today announced an expanded partnership…

AI, Collaborations, Competitor News, Product Updates

nference Accelerates Self-Supervised Language Model Training with Cerebras CS-2 System

The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM Eastern Daylight Time SUNNYVALE, Calif.–(BUSINESS WIRE)–Cerebras Systems, the pioneer in high performance artificial intelligence (AI) compute, and nference, an AI-driven health…